Protocol 
CLINICAL PROTOCOL 
Injection of Glioblastoma Patients with Tumor Cells Genetically Modified to Secrete 
Interleukin-2 (IL-2): A Phase 1 Study 
STUDY CO-CHAIRS: 
“4/94 Robert E. Sobol, M.D. 
Ivor Royston, M.D. 
San Diego Regional Cancer Center 
3099 Science Park Road, Suite 200 
San Diego, CA 92121 
Telephone: (619) 450-5990/Fax: (619) 450-3251 
CO-INVESTIGATORS : 
Habib Fakhrai, Ph.D. 
Daniel L. Shawler, B.S. 
Ruth Gjerset, Ph.D. 
Recombinant DNA Research, Volume 19 
[615] 
